8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine has been researched along with enprofylline in 1 studies
Studies (8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine) | Trials (8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine) | Recent Studies (post-2010) (8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine) | Studies (enprofylline) | Trials (enprofylline) | Recent Studies (post-2010) (enprofylline) |
---|---|---|---|---|---|
16 | 0 | 3 | 220 | 41 | 16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacobson, KA; Kim, HS; Kim, SA; Linden, J; Marshall, MA; Melman, N; Müller, CE | 1 |
1 other study(ies) available for 8-(4-carboxymethyloxy)phenyl-1,3-dipropylxanthine and enprofylline
Article | Year |
---|---|
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Topics: Animals; Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Ligands; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Xanthines | 2002 |